
ASSOCIATION OF GLUTATHIONE-S-TRANSFERASE
(GSTM1 and GSTT1) AND FTO GENE POLYMORPHISMS
WITH TYPE 2 DIABETES MELLITUS CASES
IN NORTHERN INDIA Raza ST, Abbas S, Ahmad A, Ahmed F, Zaidi ZH, Mahdi F *Corresponding Author: Syed Tasleem Raza, Ph.D., Molecular Biology Laboratory, Department of Biochemistry,
Era’s Lucknow Medical College and Hospital, Hardoi Road, Lucknow, Uttar Pradesh, India 226025. Tel.: +91-522-
240-8122; 240-8123. Fax: +91-522-240-7824. E-mail: tasleem24@gmail.com page: 47
|
ANALYSIS OF POLYMORPHISMS
GSTM1 and GSTT1 Gene Polymorphisms.
GSTM1 and GSTT1 genetic polymorphisms were
evaluated using a multiplex polymerase chain reaction
(PCR) technique (MJ Mini Thermal Cycler;
Bio-Rad Laboratories, Hercules, CA, USA). The
PCR primers were synthesized according to Arand
et al. [21]. Primers for the GSTM1 gene were: 5’-
GAA CTC CCT GAA AAG CTAA AGC-3’ and 5’-
GTT GGG CTC AAA TAT ACG GTG G-3’ and for
GSTT1: 5’-TTC CTT ACT GGT CCT CAC ATC
TC-3’ and 5’-TCA CCG GACAT GGC CAG CA-
3’. The β-globin locus was used as an internal control
to avoid false-negative readings. Primers for the
β-globin locus were: 5’-CAA CTT CAT CCA CGT
TCA CC-3’ and 5’-GAA GAG CCA AGG ACA
GGT AC-3’. The PCR reaction was carried out in a
total volume of 25 μL containing 10 pmol of each
primer, 2.5 mmol/L of MgCl2, 0.2 mmol/L of each
deoxynucleotide triphosphate, 1 unit of Taq polymerase
(Bioline Ltd., London, UK) and 100 ng of
genomic DNA. Amplification was performed by
initial denaturation at 94 oC for 5 min., followed by
30 cycles at 94 °C for 1 min., 64 °C for 1 min. and
72 °C for 1 min., and a final extension of 72 °C for
7 min. The amplified products were identified by
electrophoresis in a 1.5% agarose gel and stained
with 0.5 mg/mL (concentration) ethidium bromide.
The product lengths were 215, 480 and 268 bp for
GSTM1, GSTT1 and β-globin locus, respectively.
FTO Gene Polymorphism. The FTO SNP
(rs993 9609) was genotyped by PCR (MJ Mini Thermal
Cycler; Bio-Rad Laboratories) and restriction
fragment length polymorphism (RFLP), analyses.
Genomic DNA (20 ng) was incubated in a 10 μL
solution containing 1 × NH4 buffer, 2.5 mmol/L
magnesium, 200 mmol/L each dNTP, 20 pmol forward
(5’-AAC TGG CTC TTG AAT GAA ATA
GGA TTC AGA-3’) and reverse (5’-AGA GTA ACA
GAG ACT ATC CAA GTG CAG TAC-3’) oligonucleotide
primers [22], and 0.5 U Taq DNA polymerase
(Bioline Ltd.). The PCR mix was denaturated
at 94 °C for 5 min., followed by 20 cycles of 45
seconds at 94 °C, 45 seconds at 61 °C (dropping 0.5
°C per cycle), and 45 seconds at 72 °C. After this, the
PCR mix was incubated for 15 cycles at 45 seconds
at 94 °C, 45 seconds at 51 °C, and 45 seconds at 72
°C, followed by a final extension at 72 °C for 10
min. This was then incubated at 37 °C for 16 hours
with 2 U ScaI (New England Biolabs, Hitchin, Hertfordshire,
UK). Upon running the final products on a
3.0% agarose gel, the T allele produced a 182 bp
band and the A allele produced 154 and 28 bp bands.
Statistical Analyses. All the figures are presented
as mean ± standard deviation (SD). The genotyping
data were compared between patients and controls
using the c2 test. Other variables were compared
using the Student’s t-test for normally-distributed variables. All statistical tests were performed using
the Statistical Package for the Social Sciences, version
12 software (SPSS Inc., Chicago, IL, USA).
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|